statistiche ricercatore

Continente	#
EU - Europa	437
NA - Nord America	338
AS - Asia	204
SA - Sud America	17
AF - Africa	14
OC - Oceania	13
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.024

Nazione	#
US - Stati Uniti d'America	290
IT - Italia	184
IN - India	71
DE - Germania	64
CA - Canada	33
GB - Regno Unito	32
CN - Cina	21
FR - Francia	18
TR - Turchia	16
GR - Grecia	15
MY - Malesia	14
AU - Australia	13
MX - Messico	13
PL - Polonia	13
RO - Romania	13
ES - Italia	12
SE - Svezia	12
ID - Indonesia	10
KR - Corea	10
PT - Portogallo	10
DK - Danimarca	9
AE - Emirati Arabi Uniti	8
IE - Irlanda	8
PH - Filippine	8
BR - Brasile	7
IQ - Iraq	7
NL - Olanda	7
PK - Pakistan	7
AT - Austria	5
CL - Cile	5
EE - Estonia	5
EG - Egitto	5
JO - Giordania	5
RU - Federazione Russa	5
SG - Singapore	5
GH - Ghana	4
LV - Lettonia	4
NO - Norvegia	4
TH - Thailandia	4
UA - Ucraina	4
BD - Bangladesh	3
HR - Croazia	3
TN - Tunisia	3
AR - Argentina	2
BA - Bosnia-Erzegovina	2
GT - Guatemala	2
HK - Hong Kong	2
IL - Israele	2
JP - Giappone	2
NP - Nepal	2
PE - Perù	2
ZA - Sudafrica	2
AP - ???statistics.table.value.countryCode.AP???	1
BE - Belgio	1
CH - Svizzera	1
CO - Colombia	1
CZ - Repubblica Ceca	1
FI - Finlandia	1
IR - Iran	1
LB - Libano	1
LK - Sri Lanka	1
LT - Lituania	1
LU - Lussemburgo	1
ME - Montenegro	1
MO - Macao, regione amministrativa speciale della Cina	1
SA - Arabia Saudita	1
SI - Slovenia	1
TW - Taiwan	1
VN - Vietnam	1
Totale	1.024

Nome	#
Clinical severity instruments, file e291c0d8-dea0-cddb-e053-3a05fe0aa144	700
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment, file e291c0d4-7d0b-cddb-e053-3a05fe0aa144	336
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy, file e291c0d5-43b4-cddb-e053-3a05fe0aa144	1
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers, file e291c0d5-6665-cddb-e053-3a05fe0aa144	1
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers, file e291c0d5-68c7-cddb-e053-3a05fe0aa144	1
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis, file e291c0d5-d8eb-cddb-e053-3a05fe0aa144	1
Influence and variation of the body mass index in patients treated with etancercept for psoriasis, file e291c0d6-1db6-cddb-e053-3a05fe0aa144	1
Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: A report of two cases, file e291c0d8-bc50-cddb-e053-3a05fe0aa144	1
Totale	1.042

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	8	0	0	0	0	0	0	0	0	0	0	3	5
2019/2020	35	4	7	0	3	4	2	6	2	3	3	0	1
2020/2021	57	3	3	1	4	4	2	6	5	13	5	6	5
2021/2022	313	12	17	21	27	29	21	26	28	40	23	38	31
2022/2023	350	44	25	64	41	38	30	39	10	17	15	18	9
2023/2024	159	19	19	10	20	12	17	10	22	11	16	3	0
Totale													1.042